INNOVITAL SYSTEMS INC — Department of Defense SBIR Phase I: DHA213-003
INNOVITAL SYSTEMS INC — SBIR Phase I award from Department of Defense.
Phase I SBIR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $249,985. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code DHA213-003 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $249,985
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHA213-003
- Solicitation
- 21.3
- NAICS
- —
- Place of performance
- MD
- Period
- 2022-03-22 → 2022-10-21
Description
Future, multi-domain operational environments will require tools and systems that decrease the skill and experience level required to correctly perform critical patient care procedures, including airway management. InnoVital Systems proposes to develop the Next-Generation Nasopharyngeal Airway (NPA), a universal device with guidance that facilitates placement to the correct depth and an adaptable design that maximizes ventilation and prevents NPA collapse. Device design and materials will facilitate ease of use and safety during placement, removal, and when the device is seated. NPA securement and compatibility with key accessories (e.g., for monitoring and oxygen delivery) are also design priorities. Product features will translate well to civilian pre-hospital and in-hospital environments and markets.